PTO rejects one element of Viagra patent; Accutane user wins $25.16M verdict against Roche;

 @FiercePharma: Analysts: Effient won't be a blockbuster. Article | Follow @FiercePharma

> Pfizer's patent on its impotence drug, Viagra, was partially rejected after the U.S. Patent and Trademark Office said it wasn't different enough from a Chinese herb known as horny goat weed. Report

> A Birmingham, Alabama, man won a $25.16 million verdict Tuesday against Roche, after claiming its acne medicine led to inflammatory bowel disease. Report

> Abbott Laboratories offered to buy 20 percent more of Solvay Pharma India, the Indian subsidiary of the Belgian drug company Abbott just acquired. Report

> Denmark's Novo Nordisk has launched its new-generation Victoza drug for treatment of type 2 diabetes in the United States. Report

> AstraZeneca announced that the company provided $769.6 million in savings to 507,475 patients in 2009 through its specialised prescription saving programme AZ&Me. Report

> Berkshire Hathaway cut stakes in Johnson & Johnson, the world's largest maker of health-care products, and Procter & Gamble, the No. 1 consumer-products company, as Chairman Warren Buffett raised cash for the biggest acquisition of his career. Report

Biotech News

 @FierceBiotech: Rigel scores blockbuster $1.24B pact with AstraZeneca. Report | Follow @FierceBiotech

 @JohnCFierce: Time put Sam Waksal on its top 10 list of crooked CEOs. Report. If he raises $50M, biotech will forgive but never forget. Follow @JohnCFierce

> Johnson & Johnson's mid-stage trial for abiraterone--an oral drug which inspired a billion-dollar buyout less than a year ago--has produced another set of promising results for men with advanced, treatment-resistant prostate cancer.

> Flagship Ventures and Third Rock Ventures have joined hands to launch a new biotech company in Cambridge, MA, pumping a $35 million Series A round into a venture that will build on some cutting-edge science devoted to protein engineering and structural biology. Article

> San Diego-based Tioga Pharmaceuticals has rounded up $18 million to fund a late-stage trial which will enroll 600 patients with diarrhea predominant Irritable Bowel Syndrome. Tioga report

> CombinatoRx will be forced to wait at least until March 1 to hear if the FDA will approve its new pain drug Exalgo as regulators scramble to make up for the time lost to back-to-back blizzards. Report

And Finally... Gardasil protected most women from cervical cancer and homosexual men from anal cancer, according to new studies from Merck. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.